ID
38143
Description
Study ID: 111539 Clinical Study ID: 111539 Study Title: A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of scalating Repeat Doses of GSK249320 in Patients With Stroke Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00833989 https://clinicaltrials.gov/ct2/show/NCT00833989 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Refanezumab, Placebo Trade Name: N/A Study Indication: Ischaemic Attack, Transient The study consists of 8 visits: Day 1, Week 1 (Day 5), Week 2 (Day 10), Week 4 (Day 30), Week 8 (Day 60), Week 12 (Day 90), Week 16 (Day 112), Follow-up (F/U). All subjects will receive two doses. The first dose within 24-72 hrs after stroke the second dose 9 +/- 1 days after the first one. Each dose will be given as an intravenous infusion over 60 minutes. This document contains the concomitant medication form. It has to be filled in if concomitant medication has been taken by subject.
Link
https://clinicaltrials.gov/ct2/show/NCT00833989
Keywords
Versions (2)
- 9/22/19 9/22/19 -
- 10/5/19 10/5/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 22, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety, Pharmacokinetics and Pharmacodynamics of Refanezumab in Patients with Stroke, 111539
Concomitant medication
- StudyEvent: ODM
Description
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
Sequence Number
Data type
integer
Alias
- UMLS CUI [1]
- C2348184
Description
(Trade Name preferred)
Data type
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Description
Total daily dose
Data type
integer
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C2347852
Description
Units of concomitant medication
Data type
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0439148
Description
Route of concomitant medication
Data type
text
Alias
- UMLS CUI [1]
- C2826730
Description
Reason for Medication
Data type
text
Alias
- UMLS CUI [1]
- C2826696
Description
day month year
Data type
date
Alias
- UMLS CUI [1]
- C2826734
Description
Concomitant medication prior to study
Data type
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1883727
- UMLS CUI [1,3]
- C0332152
- UMLS CUI [1,4]
- C2347804
Description
If you tick No, please specify End date in the following item.
Data type
text
Alias
- UMLS CUI [1]
- C2826666
Description
day month year
Data type
date
Alias
- UMLS CUI [1]
- C2826744
Similar models
Concomitant medication
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C2347804 (UMLS CUI [1,4])